ArticleCureus2025
To Screen or Not to Screen Cutaneous Melanoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As with all malignancies, the challenges of detecting and treating melanomas and other cutaneous malignancies at their earliest stages remain a priority. Routine skin examinations offer physicians an easy and cost-effective way to detect cutaneous melanomas and other skin cancers in high-risk individuals. However, there are no national consensus guidelines on skin cancer screening in the United States. Primary care physicians (PCPs) and dermatologists routinely face the challenge of when and how often to perform a total body skin examination (TBSE). Furthermore, PCPs are often hesitant to perform skin examinations due to limited training and a lack of confidence in proper diagnosis. This is a case report of a high-risk individual newly diagnosed with melanoma during an annual examination. This case will highlight the current issues and controversies surrounding screening guidelines for melanomas and non-melanoma skin cancers and the need to consider targeted screening in high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.